Curi Wealth Management, LLC Abb Vie Inc. Transaction History

Curi Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $17,062 - $19,216	-124 Reduced 3.13%	3,839 $594,000
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $120,765 - $139,803	-904 Reduced 18.57%	3,963 $590,000
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $530 - $659	4 Added 0.08%	4,867 $655,000
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $11,858 - $13,656	-82 Reduced 1.66%	4,863 $775,000
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $77,453 - $92,887	560 Added 12.77%	4,945 $799,000
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $405,851 - $465,484	3,024 Added 222.19%	4,385 $589,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $22,294 - $28,343	162 Added 13.51%	1,361 $208,000
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $50,680 - $62,880	384 Added 47.12%	1,199 $194,000
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $87,555 - $110,782	815 New	815 $110,000
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $14,935 - $16,442	-146 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$80.49 - $108.67 $11,751 - $15,865	146 New	146 $15,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.